KRAS and neoplasm: Similar to the association pattern seen in TCGA survival data, in vivo tumorigenesis by KRAS-dependent human tumor cells in immune deficient mice required SNAP23 and VAMP3, but not SNAP29 (Fig. 6c; Supplementary Fig. 6A).